182 related articles for article (PubMed ID: 37292692)
1. Clonal Hematopoiesis of Indeterminate Potential is Associated with Acute Kidney Injury.
Vlasschaert C; Robinson-Cohen C; Kestenbaum B; Silver SA; Chen JC; Akwo E; Bhatraju PK; Zhang MZ; Cao S; Jiang M; Wang Y; Niu A; Siew E; Kramer HJ; Kottgen A; Franceschini N; Psaty BM; Tracy RP; Alonso A; Arking DE; Coresh J; Ballantyne CM; Boerwinkle E; Grams M; Lanktree MB; Rauh MJ; Harris RC; Bick AG
medRxiv; 2023 May; ():. PubMed ID: 37292692
[TBL] [Abstract][Full Text] [Related]
2. Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury.
Vlasschaert C; Robinson-Cohen C; Chen J; Akwo E; Parker AC; Silver SA; Bhatraju PK; Poisner H; Cao S; Jiang M; Wang Y; Niu A; Siew E; Van Amburg JC; Kramer HJ; Kottgen A; Franceschini N; Psaty BM; Tracy RP; Alonso A; Arking DE; Coresh J; Ballantyne CM; Boerwinkle E; Grams M; Zhang MZ; Kestenbaum B; Lanktree MB; Rauh MJ; Harris RC; Bick AG
Nat Med; 2024 Mar; 30(3):810-817. PubMed ID: 38454125
[TBL] [Abstract][Full Text] [Related]
3. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
[TBL] [Abstract][Full Text] [Related]
4. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic roles in clonal hematopoiesis and aging kidney-related chronic kidney disease.
Ogura Y; Mimura I
Front Cell Dev Biol; 2023; 11():1281850. PubMed ID: 37928907
[TBL] [Abstract][Full Text] [Related]
7. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE;
Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531
[TBL] [Abstract][Full Text] [Related]
8. Clonal Hematopoiesis of Indeterminate Potential and Kidney Function Decline in the General Population.
Kestenbaum B; Bick AG; Vlasschaert C; Rauh MJ; Lanktree MB; Franceschini N; Shoemaker MB; Harris RC; Psaty BM; Köttgen A; Natarajan P; Robinson-Cohen C
Am J Kidney Dis; 2023 Mar; 81(3):329-335. PubMed ID: 36241009
[TBL] [Abstract][Full Text] [Related]
9. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
[TBL] [Abstract][Full Text] [Related]
10. Clonal hematopoiesis of indeterminate potential in patients with acute coronary syndrome undergoing percutaneous coronary intervention in the absence of traditional risk factors.
Jiang Z; Li Y; Yan C; Zhang X; Zhang Q; Li J; Tian X; Qiu M; Liang Z; Ma S; Na K; Li Z; Chen S; Zhao Y; Qi Z; Liu X; Han Y
Clin Res Cardiol; 2023 Apr; 112(4):506-517. PubMed ID: 35704087
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
[TBL] [Abstract][Full Text] [Related]
12. Age-Associated
Ferrone CK; Blydt-Hansen M; Rauh MJ
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963585
[TBL] [Abstract][Full Text] [Related]
13. TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.
Svensson EC; Madar A; Campbell CD; He Y; Sultan M; Healey ML; Xu H; D'Aco K; Fernandez A; Wache-Mainier C; Libby P; Ridker PM; Beste MT; Basson CT
JAMA Cardiol; 2022 May; 7(5):521-528. PubMed ID: 35385050
[TBL] [Abstract][Full Text] [Related]
14. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.
Cobo I; Tanaka T; Glass CK; Yeang C
Curr Opin Hematol; 2022 Jan; 29(1):1-7. PubMed ID: 34654019
[TBL] [Abstract][Full Text] [Related]
15. Long-term risk associated with clonal hematopoiesis in patients with severe aortic valve stenosis undergoing TAVR.
Mas-Peiro S; Pergola G; Berkowitsch A; Meggendorfer M; Rieger MA; Vasa-Nicotera M; Dimmeler S; Zeiher AM
Clin Res Cardiol; 2023 May; 112(5):585-593. PubMed ID: 36680616
[TBL] [Abstract][Full Text] [Related]
16. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Jaiswal S; Natarajan P; Silver AJ; Gibson CJ; Bick AG; Shvartz E; McConkey M; Gupta N; Gabriel S; Ardissino D; Baber U; Mehran R; Fuster V; Danesh J; Frossard P; Saleheen D; Melander O; Sukhova GK; Neuberg D; Libby P; Kathiresan S; Ebert BL
N Engl J Med; 2017 Jul; 377(2):111-121. PubMed ID: 28636844
[TBL] [Abstract][Full Text] [Related]
17. An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesis.
Abegunde SO; Buckstein R; Wells RA; Rauh MJ
Exp Hematol; 2018 Mar; 59():60-65. PubMed ID: 29195897
[TBL] [Abstract][Full Text] [Related]
18. Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.
Yu Z; Fidler TP; Ruan Y; Vlasschaert C; Nakao T; Uddin MM; Mack T; Niroula A; Heimlich JB; Zekavat SM; Gibson CJ; Griffin GK; Wang Y; Peloso GM; Heard-Costa N; Levy D; Vasan RS; Aguet F; Ardlie KG; Taylor KD; Rich SS; Rotter JI; Libby P; Jaiswal S; Ebert BL; Bick AG; Tall AR; Natarajan P
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37498674
[TBL] [Abstract][Full Text] [Related]
19. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
[TBL] [Abstract][Full Text] [Related]
20. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]